HIMS News and Press, Hims & Hers Health Inc. Class A

2024-07-16 07:00:00 ET Summary Small-cap stocks struggled in the first half of 2024 due to economic concerns and higher interest rates, lagging behind broader market indexes. The outlook for small caps in the second half depends on timely interest rate cuts and stable economic gro...

Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...

2024-07-02 13:00:00 ET Summary 21 new analysts joined in June and are highlighted today. Each is introduced with some details on their first investment thesis on Seeking Alpha and their background. Analysts cover a range of sectors including biotech, technology, consumer staples, ...

2024-07-02 11:50:00 ET There are just a little more than 30 U.S. exchange-listed companies with market caps greater than $1 billion that more than doubled in the first half of this year. It's fair to say that most of them won't repeat the feat through the final six months of 2024. It doesn'...

2024-06-29 10:00:00 ET Shares of Hims & Hers (NYSE: HIMS) fell on Thursday after a short report was published by a short-seller. This kind of report can often send stocks lower, but is it a reason to panic or a buying opportunity? In this video, Travis Hoium digs into the report...

2024-06-27 15:07:07 ET Shares of online pharmacy Hims & Hers (NYSE: HIMS) dropped as much as 12.8% on Thursday after a short-seller wrote a report about the company. Shares recovered slightly during trading and are down 7.8% at 2:30 p.m. ET today. Hunterbrook Media put o...

2024-06-27 09:36:33 ET More on Hims & Hers Health Hims & Hers: Buy The Dip To Catch The Next Rip Hims & Hers: The Undervalued Gem Poised For Growth Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead Hims & He...

2024-06-26 04:23:00 ET Hims & Hers (NYSE: HIMS) has been on a growth tear as it reaches more customers and customizes offerings in ways traditional pharmacies can't. And those advantages open up an enormous market for the company. In this video, Travis Hoium digs into the compet...

2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...

2024-06-24 09:37:14 ET Fool.com contributor Parkev Tatevosian evaluates Hims & Hers Health (NYSE: HIMS) stock for long-term investors. *Stock prices used were the afternoon prices of June 20, 2024. The video was published on June 22, 2024. Continue reading ...